185 related articles for article (PubMed ID: 10816354)
1. Glucagon-like peptide 2: a new treatment for chemotherapy-induced enteritis.
Tavakkolizadeh A; Shen R; Abraham P; Kormi N; Seifert P; Edelman ER; Jacobs DO; Zinner MJ; Ashley SW; Whang EE
J Surg Res; 2000 Jun; 91(1):77-82. PubMed ID: 10816354
[TBL] [Abstract][Full Text] [Related]
2. Pre-treatment with insulin-like growth factor-I partially ameliorates 5-fluorouracil-induced intestinal mucositis in rats.
Cool JC; Dyer JL; Xian CJ; Butler RN; Geier MS; Howarth GS
Growth Horm IGF Res; 2005 Feb; 15(1):72-82. PubMed ID: 15701575
[TBL] [Abstract][Full Text] [Related]
3. Glucagon-like peptide-2 induces intestinal adaptation in parenterally fed rats with short bowel syndrome.
Martin GR; Wallace LE; Sigalet DL
Am J Physiol Gastrointest Liver Physiol; 2004 Jun; 286(6):G964-72. PubMed ID: 14962847
[TBL] [Abstract][Full Text] [Related]
4. Glucagon-like peptide-2 improves both acute and late experimental radiation enteritis in the rat.
Torres S; Thim L; Milliat F; Vozenin-Brotons MC; Olsen UB; Ahnfelt-Rønne I; Bourhis J; Benderitter M; François A
Int J Radiat Oncol Biol Phys; 2007 Dec; 69(5):1563-71. PubMed ID: 18035212
[TBL] [Abstract][Full Text] [Related]
5. Temporal changes in the intestinal growth promoting effects of glucagon-like peptide 2 following intestinal resection.
Kaji T; Tanaka H; Redstone H; Wallace LE; Holst JJ; Sigalet DL
J Surg Res; 2009 Apr; 152(2):271-80. PubMed ID: 19062041
[TBL] [Abstract][Full Text] [Related]
6. Systemic GLP-2 levels do not limit adaptation after distal intestinal resection.
Topstad D; Martin G; Sigalet D
J Pediatr Surg; 2001 May; 36(5):750-4. PubMed ID: 11329581
[TBL] [Abstract][Full Text] [Related]
7. Glucagon-like peptide 2 improves intestinal wound healing through induction of epithelial cell migration in vitro-evidence for a TGF--beta-mediated effect.
Bulut K; Meier JJ; Ansorge N; Felderbauer P; Schmitz F; Hoffmann P; Schmidt WE; Gallwitz B
Regul Pept; 2004 Sep; 121(1-3):137-43. PubMed ID: 15256284
[TBL] [Abstract][Full Text] [Related]
8. Role of phosphatidylinositol-3 kinase-gamma in the actions of glucagon-like peptide-2 on the murine small intestine.
Anini Y; Izzo A; Oudit GY; Backx PH; Brubaker PL
Am J Physiol Endocrinol Metab; 2007 Jun; 292(6):E1599-606. PubMed ID: 17284578
[TBL] [Abstract][Full Text] [Related]
9. The effects of variations in dose and method of administration on glucagon like peptide-2 activity in the rat.
Kaji T; Tanaka H; Holst JJ; Redstone H; Wallace L; de Heuval E; Sigalet DL
Eur J Pharmacol; 2008 Oct; 596(1-3):138-45. PubMed ID: 18762180
[TBL] [Abstract][Full Text] [Related]
10. [The protective effect of recombinant glucagons like peptide-2 on intestinal mucosa of burn rats].
Zhao Y; Wang FJ; Wang P; Chen Y; Wang SL
Zhonghua Shao Shang Za Zhi; 2007 Aug; 23(4):253-6. PubMed ID: 18095546
[TBL] [Abstract][Full Text] [Related]
11. GLP-2alpha accelerates recovery of mucosal absorptive function after intestinal ischemia/reperfusion.
Prasad R; Alavi K; Schwartz MZ
J Pediatr Surg; 2001 Apr; 36(4):570-2. PubMed ID: 11283879
[TBL] [Abstract][Full Text] [Related]
12. The effect of keratinocyte growth factor on tumour growth and small intestinal mucositis after chemotherapy in the rat with breast cancer.
Gibson RJ; Keefe DM; Clarke JM; Regester GO; Thompson FM; Goland GJ; Edwards BG; Cummins AG
Cancer Chemother Pharmacol; 2002 Jul; 50(1):53-8. PubMed ID: 12111112
[TBL] [Abstract][Full Text] [Related]
13. Loss of glucagon-like peptide-2-induced proliferation following intestinal epithelial insulin-like growth factor-1-receptor deletion.
Rowland KJ; Trivedi S; Lee D; Wan K; Kulkarni RN; Holzenberger M; Brubaker PL
Gastroenterology; 2011 Dec; 141(6):2166-2175.e7. PubMed ID: 21925122
[TBL] [Abstract][Full Text] [Related]
14. Comparative effects of glucagon-like peptide-2 (GLP-2), growth hormone (GH), and keratinocyte growth factor (KGF) on markers of gut adaptation after massive small bowel resection in rats.
Washizawa N; Gu LH; Gu L; Openo KP; Jones DP; Ziegler TR
JPEN J Parenter Enteral Nutr; 2004; 28(6):399-409. PubMed ID: 15568286
[TBL] [Abstract][Full Text] [Related]
15. Glucagon-like peptide-1 as a treatment for chemotherapy-induced mucositis.
Kissow H; Hartmann B; Holst JJ; Poulsen SS
Gut; 2013 Dec; 62(12):1724-33. PubMed ID: 23086829
[TBL] [Abstract][Full Text] [Related]
16. Treatment of suckling rats with GLP-2 plus dexamethasone increases the ileal uptake of fatty acids in later life.
Iordache C; Drozdowski L; Clandinin MT; Wild G; Todd Z; Thomson AB
Am J Physiol Gastrointest Liver Physiol; 2005 Jan; 288(1):G54-9. PubMed ID: 15591587
[TBL] [Abstract][Full Text] [Related]
17. Exogenous glucagon-like peptide-2 (GLP-2) prevents chemotherapy-induced mucositis in rat small intestine.
Kissow H; Viby NE; Hartmann B; Holst JJ; Timm M; Thim L; Poulsen SS
Cancer Chemother Pharmacol; 2012 Jul; 70(1):39-48. PubMed ID: 22729158
[TBL] [Abstract][Full Text] [Related]
18. Nutrient-stimulated GLP-2 release and crypt cell proliferation in experimental short bowel syndrome.
Martin GR; Wallace LE; Hartmann B; Holst JJ; Demchyshyn L; Toney K; Sigalet DL
Am J Physiol Gastrointest Liver Physiol; 2005 Mar; 288(3):G431-8. PubMed ID: 15388486
[TBL] [Abstract][Full Text] [Related]
19. Glucagon-like peptide-2 (GLP-2) increases small intestinal blood flow and mucosal growth in ruminating calves.
Taylor-Edwards CC; Burrin DG; Holst JJ; McLeod KR; Harmon DL
J Dairy Sci; 2011 Feb; 94(2):888-98. PubMed ID: 21257057
[TBL] [Abstract][Full Text] [Related]
20. The essential role of insulin-like growth factor-1 in the intestinal tropic effects of glucagon-like peptide-2 in mice.
Dubé PE; Forse CL; Bahrami J; Brubaker PL
Gastroenterology; 2006 Aug; 131(2):589-605. PubMed ID: 16890611
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
